Environmental impact assessment of pharmaceutical prescriptions: Does location matter?

R. Oldenkamp, M.A.J. Huijbregts, A. Hollander, A.M.J. Ragas

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

© 2014 Elsevier Ltd.A methodology was developed for the assessment and comparison of the environmental impact of two alternative pharmaceutical prescriptions. This methodology provides physicians with the opportunity to include environmental considerations in their choice of prescription. A case study with the two antibiotics ciprofloxacin and levofloxacin at three locations throughout Europe showed that the preference for a pharmaceutical might show spatial variation, i.e. comparison of two pharmaceuticals might yield different results when prescribed at different locations. This holds when the comparison is based on both the impact on the aquatic environment and the impact on human health. The relative impacts of ciprofloxacin and levofloxacin on human health were largely determined by the local handling of secondary sludge, agricultural disposal practices, the extent of secondary sewage treatment, and local food consumption patterns. The relative impacts of ciprofloxacin and levofloxacin on the aquatic environment were mostly explained by the presence of specific sewage treatment techniques, as effluents from sewage treatment plants (STPs) are the most relevant emission pathway for the aquatic environment.
Original languageEnglish
Pages (from-to)88-94
JournalChemosphere
Volume115
Issue number1
DOIs
Publication statusPublished - 2014
Externally publishedYes

Fingerprint

Dive into the research topics of 'Environmental impact assessment of pharmaceutical prescriptions: Does location matter?'. Together they form a unique fingerprint.

Cite this